Skip to content

Clinical trials

Adenocarcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20081
20092
20103
20142
20164
20171
20181
20191
20201
20211
20222
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Recruiting5
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.2
Australasian Gastro-Intestinal Trials Group2
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Queensland Centre for Gynaecological Cancer2
Abbott1
Ariad Pharmaceuticals1
AstraZeneca1
Boehringer Ingelheim1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma27
Neoplasms12
Carcinoma, Non-Small-Cell Lung9
Carcinoma8
Digestive System Neoplasms5
Neoplasm Metastasis5
Neoplasms by Site5
Stomach Neoplasms5
Lung Neoplasms4
Neoplasms by Histologic Type4

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.